https://www.synconaltd.com/portfolio/commercial-companies/autolus-therapeutics/
Autolus Therapeutics | Commercial companies | Portfolio | Syncona
Autolus is a clinical-stage biopharmaceutical company focusing on the development of precisely targeted, controlled and highly active T effector cell therapies.
companies portfolio syncona
https://www.synconaltd.com/news-insights/news/autolus-therapeutics-announces-first-patient-dosed-in-phase-1-trial-of-obecabtagene-autoleucel-obe-cel-in-patients-with-progressive-multiple-sclerosis/
Autolus Therapeutics Announces First Patient Dosed in Phase 1 Trial of Obecabtagene Autoleucel...
autolus therapeuticsannounces
https://www.synconaltd.com/news-insights/news/autolus-therapeutics-presents-clinical-data-updates-at-the-american-college-of-rheumatology-convergence-2025/
Autolus Therapeutics Presents Clinical Data Updates at the American College of Rheumatology...
autolus therapeuticspresents